Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
SNES vs CTVA
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Inputs
SNES vs CTVA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Agricultural Inputs |
| Market Cap | $8M | $54.89B |
| Revenue (TTM) | $2M | $17.89B |
| Net Income (TTM) | $-6M | $1.16B |
| Gross Margin | 62.5% | 33.5% |
| Operating Margin | -292.9% | 13.8% |
| Forward P/E | — | 22.3x |
| Total Debt | $3M | $2.58B |
| Cash & Equiv. | $8M | $4.52B |
SNES vs CTVA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SenesTech, Inc. (SNES) | 100 | 0.0 | -100.0% |
| Corteva, Inc. (CTVA) | 100 | 299.4 | +199.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SNES vs CTVA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SNES is the clearest fit if your priority is growth exposure.
- Rev growth 19.6%, EPS growth 78.0%, 3Y rev CAGR 29.7%
- 19.6% revenue growth vs CTVA's 2.9%
CTVA carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.29, yield 0.9%
- 195.9% 10Y total return vs SNES's -100.0%
- Lower volatility, beta 0.29, Low D/E 10.6%, current ratio 1.43x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.6% revenue growth vs CTVA's 2.9% | |
| Quality / Margins | 6.5% margin vs SNES's -287.4% | |
| Stability / Safety | Beta 0.29 vs SNES's 1.71, lower leverage | |
| Dividends | 0.9% yield; 5-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +32.1% vs SNES's -41.9% | |
| Efficiency (ROA) | 2.7% ROA vs SNES's -61.6%, ROIC 8.5% vs -159.0% |
SNES vs CTVA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SNES vs CTVA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CTVA leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CTVA is the larger business by revenue, generating $17.9B annually — 8054.5x SNES's $2M. CTVA is the more profitable business, keeping 6.5% of every revenue dollar as net income compared to SNES's -2.9%. On growth, CTVA holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2M | $17.9B |
| EBITDAEarnings before interest/tax | -$6M | $3.4B |
| Net IncomeAfter-tax profit | -$6M | $1.2B |
| Free Cash FlowCash after capex | -$6M | $2.1B |
| Gross MarginGross profit ÷ Revenue | +62.5% | +33.5% |
| Operating MarginEBIT ÷ Revenue | -2.9% | +13.8% |
| Net MarginNet income ÷ Revenue | -2.9% | +6.5% |
| FCF MarginFCF ÷ Revenue | -2.7% | +11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.0% | +11.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +83.1% | +12.6% |
Valuation Metrics
CTVA leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $8M | $54.9B |
| Enterprise ValueMkt cap + debt − cash | $3M | $52.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.75x | 51.10x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 22.30x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.28x |
| EV / EBITDAEnterprise value multiple | — | 13.85x |
| Price / SalesMarket cap ÷ Revenue | 3.46x | 3.15x |
| Price / BookPrice ÷ Book value/share | 5.03x | 2.26x |
| Price / FCFMarket cap ÷ FCF | — | 19.50x |
Profitability & Efficiency
CTVA leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
CTVA delivers a 4.6% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-83 for SNES. CTVA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNES's 0.28x. On the Piotroski fundamental quality scale (0–9), CTVA scores 6/9 vs SNES's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -82.9% | +4.6% |
| ROA (TTM)Return on assets | -61.6% | +2.7% |
| ROICReturn on invested capital | -159.0% | +8.5% |
| ROCEReturn on capital employed | -88.1% | +8.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.28x | 0.11x |
| Net DebtTotal debt minus cash | -$5M | -$1.9B |
| Cash & Equiv.Liquid assets | $8M | $4.5B |
| Total DebtShort + long-term debt | $3M | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | -380.17x | 5.82x |
Total Returns (Dividends Reinvested)
CTVA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTVA five years ago would be worth $17,540 today (with dividends reinvested), compared to $4 for SNES. Over the past 12 months, CTVA leads with a +32.1% total return vs SNES's -41.9%. The 3-year compound annual growth rate (CAGR) favors CTVA at 13.3% vs SNES's -79.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -33.5% | +20.9% |
| 1-Year ReturnPast 12 months | -41.9% | +32.1% |
| 3-Year ReturnCumulative with dividends | -99.1% | +45.5% |
| 5-Year ReturnCumulative with dividends | -100.0% | +75.4% |
| 10-Year ReturnCumulative with dividends | -100.0% | +195.9% |
| CAGR (3Y)Annualised 3-year return | -79.1% | +13.3% |
Risk & Volatility
CTVA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CTVA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than SNES's 1.71 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTVA currently trades 95.5% from its 52-week high vs SNES's 23.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.71x | 0.29x |
| 52-Week HighHighest price in past year | $6.24 | $85.63 |
| 52-Week LowLowest price in past year | $1.41 | $60.54 |
| % of 52W HighCurrent price vs 52-week peak | +23.6% | +95.5% |
| RSI (14)Momentum oscillator 0–100 | 38.2 | 64.4 |
| Avg Volume (50D)Average daily shares traded | 35K | 3.4M |
Analyst Outlook
CTVA leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
CTVA is the only dividend payer here at 0.86% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $88.17 |
| # AnalystsCovering analysts | — | 37 |
| Dividend YieldAnnual dividend ÷ price | — | +0.9% |
| Dividend StreakConsecutive years of raises | 0 | 5 |
| Dividend / ShareAnnual DPS | — | $0.71 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.0% |
CTVA leads in 6 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics.
SNES vs CTVA: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is SNES or CTVA a better buy right now?
For growth investors, SenesTech, Inc.
(SNES) is the stronger pick with 19. 6% revenue growth year-over-year, versus 2. 9% for Corteva, Inc. (CTVA). Corteva, Inc. (CTVA) offers the better valuation at 51. 1x trailing P/E (22. 3x forward), making it the more compelling value choice. Analysts rate Corteva, Inc. (CTVA) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SNES or CTVA?
Over the past 5 years, Corteva, Inc.
(CTVA) delivered a total return of +75. 4%, compared to -100. 0% for SenesTech, Inc. (SNES). Over 10 years, the gap is even starker: CTVA returned +195. 9% versus SNES's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SNES or CTVA?
By beta (market sensitivity over 5 years), Corteva, Inc.
(CTVA) is the lower-risk stock at 0. 29β versus SenesTech, Inc. 's 1. 71β — meaning SNES is approximately 482% more volatile than CTVA relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 28% for SenesTech, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — SNES or CTVA?
By revenue growth (latest reported year), SenesTech, Inc.
(SNES) is pulling ahead at 19. 6% versus 2. 9% for Corteva, Inc. (CTVA). On earnings-per-share growth, the picture is similar: SenesTech, Inc. grew EPS 78. 0% year-over-year, compared to 23. 1% for Corteva, Inc.. Over a 3-year CAGR, SNES leads at 29. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SNES or CTVA?
Corteva, Inc.
(CTVA) is the more profitable company, earning 6. 3% net margin versus -287. 4% for SenesTech, Inc. — meaning it keeps 6. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTVA leads at 15. 1% versus -292. 9% for SNES. At the gross margin level — before operating expenses — SNES leads at 62. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — SNES or CTVA?
In this comparison, CTVA (0.
9% yield) pays a dividend. SNES does not pay a meaningful dividend and should not be held primarily for income.
07Is SNES or CTVA better for a retirement portfolio?
For long-horizon retirement investors, Corteva, Inc.
(CTVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 9% yield, +195. 9% 10Y return). SenesTech, Inc. (SNES) carries a higher beta of 1. 71 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CTVA: +195. 9%, SNES: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SNES and CTVA?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SNES is a small-cap high-growth stock; CTVA is a mid-cap quality compounder stock. CTVA pays a dividend while SNES does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.